Ropharma estimates a 25% growth in profit this year to RON9 million, and a 5% growth in sales, to RON430 million.
The company ranks eighth among local pharmaceutical distributors, with a 3.3% market share, while on the retail segment, it ranks fifth.
Ropharma employs over 900 people and has two production units, in Targu Mures and Chisinau, where it makes nutritional supplements and medicines. The distribution company has five warehouses and 1,200 client pharmacies, besides its own drugstore network of 115 units.
Businessman Mihai Miron indirectly owns 31.78% of Ropharma. He controls 14.12% via Rimia Investments and 17.66% via ADD Pharmaceuticals, both registered in Cyprus. U.S.-registered Arrow Pharmaceuticals owns 31.29% in Ropharma. (EUR1=RON4.4293)